CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers.
Immobilized Biotinylated Human CD24, His Tag at 0.5ug/ml (100ul/well) on the streptavidin precoated plate (5ug/ml). Dose response curve for Anti-CD24 Antibody, hFc Tag with the EC50 of 9.6ng/ml determined by ELISA.
Immobilized Human CD24, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-CD24 Antibody, hFc Tag with the EC50 of 47.0ng/ml determined by ELISA.
Human CD24 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of Cynomolgus CD24 is greater than 95% as determined by SEC-HPLC.